Cargando…

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer

BACKGROUND: Cervical cancer is the fourth most frequent gynecological malignancy across the world. Immunotherapies have proved to improve prognosis of cervical cancer. However, few studies on immune-related prognostic signature had been reported in cervical cancer. METHODS: Raw data and clinical inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Rongjia, Jin, Chengwen, Bu, Hualei, Xiang, Jiangdong, Zhou, Lina, Jin, Chengjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148954/ https://www.ncbi.nlm.nih.gov/pubmed/35651784 http://dx.doi.org/10.3389/fonc.2022.861392

Ejemplares similares

Construction of a prognostic signature for serous ovarian cancer based on lactate metabolism-related genes
por: Xiang, Jiangdong, et al.
Publicado: (2022)

Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis
por: Su, Rongjia, et al.
Publicado: (2021)

Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA
por: Su, Rongjia, et al.
Publicado: (2021)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
por: Chen, Yu, et al.
Publicado: (2021)

Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
por: Jin, Chengwen, et al.
Publicado: (2022)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhou, Shuguang, et al.
Publicado: (2022)

Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer
por: Zhang, Hang, et al.
Publicado: (2021)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
por: Liu, Yunze, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
por: Liu, Yanqing, et al.
Publicado: (2022)

Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma
por: Sun, Qi, et al.
Publicado: (2022)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Xing, Chaoqun, et al.
Publicado: (2022)

Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study
por: Fu, Mengdi, et al.
Publicado: (2022)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Commentary: Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
por: Du, Yi-Heng
Publicado: (2023)

Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma
por: Li, Su-Ran, et al.
Publicado: (2022)

Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer
por: Jin, Yi, et al.
Publicado: (2023)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
por: Pan, Jingxin, et al.
Publicado: (2020)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma
por: Xiao, Bo, et al.
Publicado: (2020)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer
por: Zhong, Jianxin, et al.
Publicado: (2023)

Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer
por: Ma, Xiao-Bo, et al.
Publicado: (2021)

Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma
por: Wei, Tao, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes
por: Liu, Huan, et al.
Publicado: (2021)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g48a8ran138gh8mhr6nsdco949